The Therapeutic Landscape in Chronic Cough
John A. Smith
Abstract
In recent years, there has been a substantial increase in the development of antitussive therapies and the first new therapy, gefapixant has been licenced in Europe. This review describes current unlicenced treatments for chronic cough and details treatments currently in development for refractory chronic cough and cough in idiopathic pulmonary fibrosis, as well as compounds previously explored.
Topics & Concepts
Chronic coughMedicineRefractory (planetary science)Intensive care medicineInternal medicineAsthmaPhysicsAstrobiologyRespiratory and Cough-Related ResearchAsthma and respiratory diseasesPediatric health and respiratory diseases